Toxicity-structure activity evaluation of limonoids from Swietenia species on Artemia salina

CONTEXT: Many plant extracts and compounds are being investigated for their cytotoxicity and hence their medicinal or therapeutic properties. Reports of toxicity studies with limonoid analogs have been sparse and have involved mainly crude extracts. In this study, individual natural limonoids have been isolated and their toxicity manipulated via semisynthesis.

OBJECTIVE: The lethality of limonoid analogs from Swietenia macrophylla King and Swietenia aubrevilleana Stehlé & Cusin (Meliaceae) against Artemia salina Leach was determined.

MATERIALS AND METHODS: Four known natural limonoids were isolated from the dry ground seeds of S. macrophylla and S. aubrevilleana, modified using acylation and hydrolysis reactions and tested in A. salina lethality assays at 1-400 ppm. A 50% lethal concentration (LC(50)) was determined by probit analysis.

RESULTS: Higher levels of toxicity were achieved in most of the prepared analogs compared with the parent natural limonoids. The compound showing the highest toxicity with LC(50) 3.9 ppm was 3-O-benzoyl-3-detigloylisoswietenine (20). Other analogs with high toxicity were 6-O-benzoylswietenolide (7), 6-O-benzoylswietenine (17), and 3,6-O,O-dipropionylswietenolide (9), which showed LC(50) values of 4.3, 7.5, and 28.5 ppm, respectively.

DISCUSSION AND CONCLUSIONS: Toxicity can be improved via semisynthesis. The compounds exhibiting high toxicity (low LC(50)) may be good candidates for cytotoxicity studies.

Medienart:

E-Artikel

Erscheinungsjahr:

2012

Erschienen:

2012

Enthalten in:

Zur Gesamtaufnahme - volume:50

Enthalten in:

Pharmaceutical biology - 50(2012), 2 vom: 27. Feb., Seite 264-7

Sprache:

Englisch

Beteiligte Personen:

Fowles, Robert G [VerfasserIn]
Mootoo, Baldwin S [VerfasserIn]
Ramsewak, Russel S [VerfasserIn]
Khan, Ayub [VerfasserIn]

Links:

Volltext

Themen:

Comparative Study
Journal Article
Limonins
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 04.05.2012

Date Revised 12.01.2012

published: Print

Citation Status MEDLINE

doi:

10.3109/13880209.2011.581670

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM214470539